SCHEMBL7410481

SCHEMBL7410481

Cn1c(C(N)=O)c(NC(=O)c2ccc(Cl)cc2)c(=O)n(C)c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
HTT P42858 3/20 0.52
LMNA P02545 2/20 0.48
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
HPGD P15428 2/20 0.43
GFER P55789 1/20 0.43
KDM4E B2RXH2 5/20 0.43
RXFP1 Q9HBX9 2/20 0.43
CDC7 O00311 1/20 0.42
PLK4 O00444 1/20 0.42
DYRK3 O43781 1/20 0.42
ROCK2 O75116 1/20 0.42
PRKD3 O94806 1/20 0.42
MAP4K4 O95819 1/20 0.42
PRKCG P05129 1/20 0.42
INSR P06213 1/20 0.42
CDK1 P06493 1/20 0.42
PIM1 P11309 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7409608 0.84 HTT (0.62) ALDH1A1SMN1; SMN2HTTLMNARAB9A
SCHEMBL5094443 0.70 MAPT (0.50) ALDH1A1HTTLMNARAB9ANPC1
SCHEMBL10616161 0.68 POLB (0.44) ALDH1A1SMN1; SMN2HTTLMNAHPGD
SCHEMBL15775229 0.66 KDM4E (0.57) ALDH1A1SMN1; SMN2HTTLMNARAB9A
SCHEMBL11123393 0.64 RXFP1 (0.59) ALDH1A1SMN1; SMN2HTTLMNARAB9A
SCHEMBL15775343 0.63 LMNA (0.58) ALDH1A1SMN1; SMN2LMNANPC1KDM4E
SCHEMBL9767723 0.62 NPC1 (0.76) SMN1; SMN2LMNARAB9ANPC1MAPT
Hexamethylbenzene SCHEMBL27628945 0.62 MAP4K4 (0.57) ALDH1A1LMNAKDM4EMAP4K4CYP2C19
SCHEMBL10939703 0.62 NPC1 (0.76) SMN1; SMN2LMNARAB9ANPC1MAPT
SCHEMBL611657 0.62 NPC1 (0.76) SMN1; SMN2LMNARAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002000651-A2 FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-01-03 WO disclosed